Xavier Intes

Dr. Xavier Intes

Biomedical Engineering department, Rensselaer Polytechnic Institute, 110 8th street, JEC 7036, Troy, NY 12180, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JSJason T. Smith
Jason T. Smith
RYRuoyang Yao
Ruoyang Yao
NSNattawut Sinsuebphon
Nattawut Sinsuebphon
ARAlena Rudkouskaya
Alena Rudkouskaya
NUNathan Un
Nathan Un
XIXavier Intes
Xavier Intes
Fluorescence lifetime imaging (FLI) provides unique quantitative information in biomedical and molecular biology studies but relies on complex data-fitting techniques to derive the quantities of interest. Herein, we propose a fit-free approach in FLI image formation that is based on deep learning (DL) to quantify fluorescence decays simultaneously over a whole image and at fast speeds. We report on a deep neural network (DNN) architecture, named fluorescence lifetime imaging network (FLI-Net) that is designed and trained for different classes of experiments, including visible FLI and near-infrared (NIR) FLI microscopy (FLIM) and NIR gated macroscopy FLI (MFLI). FLI-Net outputs quantitatively the spatially resolved lifetime-based parameters that are typically employed in the field. We validate the utility of the FLI-Net framework by performing quantitative microscopic and preclinical lifetime-based studies across the visible and NIR spectra, as well as across the 2 main data acquisition technologies. These results demonstrate that FLI-Net is well suited to accurately quantify complex fluorescence lifetimes in cells and, in real time, in intact animals without any parameter settings. Hence, FLI-Net paves the way to reproducible and quantitative lifetime studies at unprecedented speeds, for improved dissemination and impact of FLI in many important biomedical applications ranging from fundamental discoveries in molecular and cellular biology to clinical translation.

5 June 2017 in Nature Photonics
Verified
Journal Article
Closed access
PDF file
QPQi Pian
Qi Pian
RYRuoyang Yao
Ruoyang Yao
NSNattawut Sinsuebphon
Nattawut Sinsuebphon
XIXavier Intes
Xavier Intes

20 July 2022 in Neurophotonics
Verified
Journal Article
Open access
PDF file
CECondell Eastmond
Condell Eastmond
ASAseem Subedi
Aseem Subedi
SDSuvranu De
Suvranu De
XIXavier Intes
Xavier Intes
Over the last two decades, functional near-infrared spectroscopy (fNIRS) has become a well-established neuroimaging modality to monitor brain activity.1 The ability of fNIRS to quantify cortical tissue hemodynamics over a long time, with relative high-spatial sampling and temporal resolution, has enabled its adoption in numerous clinical settings.2,3 fNIRS offers the unique advantage to be employed in freely mobile subjects with less restrictions than electroencephalography (EEG) or functional magnetic resonance imaging (fMRI). This permits the deployment of fNIRS in naturalistic scenarios and in patient populations that are typically not considered suitable for EEG or fMRI imaging.4 Still, fNIRS faces numerous challenges for increased clinical adoption due to experimental settings,5 variations in statistical results,6 etc. Of importance, current trends in fNIRS aim to improve spatial resolution via increased spatial sampling, improve cortical sensitivity using data processing to remove unwanted physiological noise, improve quantification by anatomical coregistration, and increase robustness via artifact identification and removal.7 Current algorithmic implementations, however, require a high level of expertise to set up parameters that can be system- and/or application-specific but also greatly impact the interpretability of the processed data. Moreover, the computational cost of these methods does not lend itself to bedside implementations. Following a ubiquitous trend in the field of data processing and analysis, new approaches leveraging developments in deep learning (DL) have been recently proposed to help overcome these caveats to a large extent.

1 July 2012 in Biomaterials
Verified
Journal Article
Closed access
LZLingling Zhao
Lingling Zhao
VLVivian K. Lee
Vivian K. Lee
SYSeung-Schik Yoo
Seung-Schik Yoo
GDGuohao Dai
Guohao Dai
XIXavier Intes
Xavier Intes

1 September 2019 in Acta Biomaterialia
Verified
Journal Article
Closed access
DKDavid Kingsley
David Kingsley
CRCassandra L. Roberge
Cassandra L. Roberge
ARAlena Rudkouskaya
Alena Rudkouskaya
DFDenzel E. Faulkner
Denzel E. Faulkner
MBMargarida Barroso
Margarida Barroso
DCDavid Corr
David Corr

14 September 2018 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
JAJoseph P. Angelo
Joseph P. Angelo
SCSez-Jade Chen
Sez-Jade Chen
MOMarien Ochoa
Marien Ochoa
Ulas SunarUlas Sunar
Ulas Sunar
SGSylvain Gioux
Sylvain Gioux
XIXavier Intes
Xavier Intes
The ability to probe deep tissues with light for biomedical applications has been recognized since the scientific reports published as early as the late 1800s for monitoring brain hemorrhage1 and early 1900s for imaging breast cancer2 and performing tissue oximetry.3,4 Since then, diffuse optical imaging techniques have greatly benefited numerous biomedical fields. Mainly, the goal of these optical techniques is to characterize optical properties of tissue using light from the ultraviolet to the infrared spectral region. The specific light–tissue interaction enables monitoring of a vast array of tissue characteristics, including structural, physiological, metabolic, and molecular properties.